{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T21:11:24Z","timestamp":1786396284910,"version":"build-2736575974"},"reference-count":93,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T00:00:00Z","timestamp":1704412800000},"content-version":"vor","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.intimp.2022.109583","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T18:54:55Z","timestamp":1672944895000},"page":"109583","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosis by increasing MMP-9 in a doxorubicin-induced nephrotoxicity mouse model"],"prefix":"10.1016","volume":"115","author":[{"given":"Walyson Coelho","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin\u00edcius Amorim","family":"Beltrami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel Henrique","family":"Campolina-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celso Martins","family":"Queiroz-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo M.","family":"Florentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9ssica Rayssa","family":"Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9bora Gonzaga","family":"Martins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William Antonio","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia Corr\u00eaa","family":"Barroso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia Michelle","family":"Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Pedro","family":"de Souza-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franciel Batista","family":"F\u00e9lix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Fernandes","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cleida Aparecida","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels Olsen Saraiva","family":"C\u00e2mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milene Alvarenga","family":"Rachid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro Martins","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara Maximino","family":"Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Pinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.intimp.2022.109583_b0005","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1177\/1470320308098343","article-title":"Experimental models for nephropathy","volume":"9","author":"Balakumar","year":"2008","journal-title":"J. Renin Angiotensin Aldosterone Syst."},{"key":"10.1016\/j.intimp.2022.109583_b0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1053\/ajkd.2003.50007","article-title":"Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey","volume":"41","author":"Coresh","year":"2003","journal-title":"Am. J. Kidney Dis."},{"issue":"6","key":"10.1016\/j.intimp.2022.109583_b0015","doi-asserted-by":"crossref","first-page":"e66082","DOI":"10.1371\/journal.pone.0066082","article-title":"Beneficial Effects of the Activation of the Angiotensin-(1\u20137) Mas Receptor in a Murine Model of Adriamycin-Induced Nephropathy","volume":"8","author":"Silveira","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2022.109583_b0020","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000369346","article-title":"Combination Therapy with Telmisartan and Oxacalcitriol Suppresses the Progression of Murine Adriamycin Nephropathy","volume":"129","author":"Jeong","year":"2015","journal-title":"Nephron"},{"issue":"6","key":"10.1016\/j.intimp.2022.109583_b0025","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrneph.2011.51","article-title":"Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy","volume":"7","author":"Navarro-Gonz\u00e1lez","year":"2011","journal-title":"Nat. Rev. Nephrol."},{"issue":"1","key":"10.1016\/j.intimp.2022.109583_b0030","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneph.2015.175","article-title":"Innate immunity in diabetes and diabetic nephropathy","volume":"12","author":"Wada","year":"2016","journal-title":"Nat. Rev. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0035","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","article-title":"Progressive adriamycin nephropathy in mice: Sequence of histologic and immunohistochemical events","volume":"58","author":"Wang","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2022.109583_b0040","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/cas.12612","article-title":"Expression of BAF57 in ovarian cancer cells and drug sensitivity","volume":"106","author":"Yamaguchi","year":"2015","journal-title":"Cancer Sci."},{"key":"10.1016\/j.intimp.2022.109583_b0045","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-015-0121-9","article-title":"Local administration of a novel Toll-like receptor 7 agonist in combination with doxorubicin induces durable tumouricidal effects in a murine model of T cell lymphoma","volume":"8","author":"Zhu","year":"2015","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.intimp.2022.109583_b0050","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1080\/08860220902883020","article-title":"Effects of vitamin D3 (cholecalciferol) on adriamycin-induced nephrotoxicity","volume":"31","author":"Dabak","year":"2009","journal-title":"Ren. Fail."},{"issue":"5","key":"10.1016\/j.intimp.2022.109583_b0055","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00011-015-0813-1","article-title":"Sim\u00f5es e Silva, The experimental model of nephrotic syndrome induced by Doxorubicin in rodents: an update","volume":"64","author":"Pereira","year":"2015","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2022.109583_b0060","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1152\/ajprenal.00502.2010","article-title":"Doxorubicin-induced glomerulosclerosis with proteinuria in GFP-GABARAP transgenic mice","volume":"302","author":"Takagi-Akiba","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0065","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1681\/ASN.2014050468","article-title":"Role of Myeloid-Derived Suppressor Cells in Glucocorticoid-Mediated Amelioration of FSGS","volume":"26","author":"Li","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0070","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1159\/000108102","article-title":"Inhibition of JAK\/STAT Signaling Ameliorates Mice Experimental Nephrotic Syndrome","volume":"27","author":"Li","year":"2007","journal-title":"Am. J. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0075","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1159\/000430296","article-title":"Induction of C-Mip by IL-17 Plays an Important Role in Adriamycin-Induced Podocyte Damage","volume":"36","author":"Liu","year":"2015","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.intimp.2022.109583_b0080","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1681\/ASN.2010111196","article-title":"Valproic acid attenuates proteinuria and kidney injury","volume":"22","author":"van Beneden","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1152\/ajprenal.00669.2011","article-title":"Interleukin-18 binding protein therapy is protective in adriamycin nephropathy","volume":"304","author":"Wyburn","year":"2013","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"6","key":"10.1016\/j.intimp.2022.109583_b0090","doi-asserted-by":"crossref","first-page":"e67471","DOI":"10.1371\/journal.pone.0067471","article-title":"Resolvin D1 Protects Podocytes in Adriamycin-Induced Nephropathy through Modulation of 14\u20133-3\u03b2 Acetylation","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2022.109583_b0095","doi-asserted-by":"crossref","DOI":"10.1186\/1741-7015-11-96","article-title":"Phosphodiesterase 4-targeted treatments for autoimmune diseases","volume":"11","author":"Kumar","year":"2013","journal-title":"BMC Med."},{"key":"10.1016\/j.intimp.2022.109583_b0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.pharmthera.2013.04.006","article-title":"Resolution of inflammation: Mechanisms and opportunity for drug development","volume":"139","author":"Alessandri","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.intimp.2022.109583_b0105","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109583_b0110","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0165-6147(97)90613-1","article-title":"Phosphodiesterase (PDE)4 inhibitors: anti-inflammatory drugs of the future?","volume":"18","author":"Teixeira","year":"1997","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.intimp.2022.109583_b0115","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.bcp.2009.04.030","article-title":"Cyclic AMP enhances resolution of allergic pleurisy by promoting inflammatory cell apoptosis via inhibition of PI3K\/Akt and NF-\u03baB","volume":"78","author":"Sousa","year":"2009","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109583_b0120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1038\/sj.bjp.0704336","article-title":"Effects of inhibition of PDE4 and TNF-alpha on local and remote injuries following ischaemia and reperfusion injury","volume":"134","author":"Souza","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109583_b0125","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/rcmb.2015-0083OC","article-title":"Inhibition of phosphodiesterase-4 during pneumococcal pneumonia reduces inflammation and lung injury in mice","volume":"55","author":"Tavares","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.intimp.2022.109583_b0130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0014-2999(00)00330-7","article-title":"Anti-inflammatory and analgesic effects of the phosphodiesterase 4 inhibitor rolipram in a rat model of arthritis","volume":"399","author":"Francischi","year":"2000","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109583_b0135","doi-asserted-by":"crossref","unstructured":"E. Mammadov, I.A. Aridogan, V. Izol, A. Acikalin, D. Abat, A. Tuli, Y. Bayazit, Protective Effects of Phosphodiesterase-4-specific Inhibitor Rolipram on Acute Ischemia-reperfusion Injury in Rat Kidney, Urology 80 (2012) 1390.e1\u20131390.e6. https:\/\/doi.org\/10.1016\/J.UROLOGY.2012.07.028.","DOI":"10.1016\/j.urology.2012.07.028"},{"key":"10.1016\/j.intimp.2022.109583_b0140","doi-asserted-by":"crossref","unstructured":"J.B. Taylor, D.J. Triggle, Comprehensive medicinal chemistry II, Elsevier, Amsterdam,\u00a0London, 2007. https:\/\/doi.org\/10.1002\/qsar.19910100410.","DOI":"10.1002\/qsar.19910100410"},{"key":"10.1016\/j.intimp.2022.109583_b0145","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1189\/jlb.0809540","article-title":"PDE4 inhibition drives resolution of neutrophilic inflammation by inducing apoptosis in a PKA-PI3K\/Akt-dependent and NF-kappaB-independent manner","volume":"87","author":"Sousa","year":"2010","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2022.109583_b0150","doi-asserted-by":"crossref","first-page":"105078","DOI":"10.1016\/j.phrs.2020.105078","article-title":"Phosphodiesterase-4 enzyme as a therapeutic target in neurological disorders","volume":"160","author":"Bhat","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.intimp.2022.109583_b0155","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.jaci.2019.06.047","article-title":"Crisaborole and atopic dermatitis skin biomarkers: An intrapatient randomized trial","volume":"144","author":"Bissonnette","year":"2019","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109583_b0160","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1159\/000095677","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, reduces airway hyperresponsiveness after allergen challenge","volume":"74","author":"Louw","year":"2007","journal-title":"Respiration"},{"key":"10.1016\/j.intimp.2022.109583_b0165","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jaci.2005.04.023","article-title":"Roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor, attenuates allergen-induced asthmatic reactions","volume":"116","author":"van Schalkwyk","year":"2005","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.intimp.2022.109583_b0170","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3389\/fphar.2021.518345","article-title":"Phosphodiesterase-4 Inhibitors for Non-COPD Respiratory Diseases","volume":"12","author":"Kawamatawong","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.intimp.2022.109583_b0175","doi-asserted-by":"crossref","first-page":"E1720","DOI":"10.1210\/jc.2011-2886","article-title":"Effect of the phosphodiesterase 4 inhibitor roflumilast on glucose metabolism in patients with treatment-naive, newly diagnosed type 2 diabetes mellitus","volume":"97","author":"Wouters","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.intimp.2022.109583_b0180","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1177\/0960327119829521","article-title":"Roflumilast, a phosphodiesterase 4 inhibitor, attenuates cadmium-induced renal toxicity via modulation of NF-\u03baB activation and induction of NQO1 in rats","volume":"38","author":"Ansari","year":"2019","journal-title":"Hum. Exp. Toxicol."},{"key":"10.1016\/j.intimp.2022.109583_b0185","doi-asserted-by":"crossref","first-page":"F576","DOI":"10.1152\/ajprenal.00477.2019","article-title":"Inhibition of PDE4\/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury","volume":"318","author":"Xu","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0190","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1189\/jlb.0112008","article-title":"Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis","volume":"92","author":"Vago","year":"2012","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.intimp.2022.109583_b0195","doi-asserted-by":"crossref","unstructured":"S. Akilesh, Normal Kidney Function and Structure, Pathobiology of Human Disease: A Dynamic Encyclopedia of Disease Mechanisms. (2014) 2716\u20132733. https:\/\/doi.org\/10.1016\/B978-0-12-386456-7.05402-2.","DOI":"10.1016\/B978-0-12-386456-7.05402-2"},{"issue":"5","key":"10.1016\/j.intimp.2022.109583_b0200","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1053\/j.ajkd.2016.03.003","article-title":"AJKD Atlas of Renal Pathology: Ischemic Acute Tubular Injury","volume":"67","author":"Fogo","year":"2016","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2022.109583_b0205","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1002\/pros.23349","article-title":"Profile of cell proliferation and apoptosis activated by the intrinsic and extrinsic pathways in the prostate of aging rats","volume":"77","author":"Gonzaga","year":"2017","journal-title":"Prostate"},{"key":"10.1016\/j.intimp.2022.109583_b0210","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1042\/CS20180547","article-title":"Alamandine attenuates arterial remodelling induced by transverse aortic constriction in mice","volume":"133","author":"de Souza-Neto","year":"2019","journal-title":"Clin. Sci."},{"issue":"10","key":"10.1016\/j.intimp.2022.109583_b0215","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00011-004-1299-4","article-title":"Production and in vivo effects of chemokines CXCL1-3\/KC and CCL2\/JE in a model of inflammatory angiogenesis in mice","volume":"53","author":"Barcelos","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.intimp.2022.109583_b0220","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1681\/ASN.2014060613","article-title":"Extracellular superoxide dismutase protects against proteinuric kidney disease","volume":"26","author":"Tan","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0225","first-page":"e2445","article-title":"Detection of Functional Matrix Metalloproteinases by Zymography","author":"Hu","year":"2010","journal-title":"JoVE (J. Visual. Exp.)"},{"key":"10.1016\/j.intimp.2022.109583_b0230","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1111\/bph.14153","article-title":"Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers","volume":"175","author":"Curtis","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109583_b0235","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1440-1797.2010.01383.x","article-title":"Adriamycin nephropathy: a model of focal segmental glomerulosclerosis","volume":"16","author":"Lee","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.intimp.2022.109583_b0240","doi-asserted-by":"crossref","first-page":"13758","DOI":"10.1074\/jbc.M117.800391","article-title":"The resolution of acute inflammation induced by cyclic AMP is dependent on annexin A1","volume":"292","author":"Lima","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.intimp.2022.109583_b0245","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1046\/j.1523-1755.2003.00868.x","article-title":"Proteinuria and the risk of developing end-stage renal disease","volume":"63","author":"Iseki","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2022.109583_b0250","first-page":"15","article-title":"Genetic Advances in Childhood Nephrological Disorders: The Genetics of Nephrotic Syndrome","volume":"5","author":"Rheault","year":"2016","journal-title":"J. Pediatr. Genet."},{"key":"10.1016\/j.intimp.2022.109583_b0255","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41573-021-00242-0","article-title":"The glomerular filtration barrier: a structural target for novel kidney therapies","volume":"20","author":"Daehn","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.intimp.2022.109583_b0260","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/ndt\/16.1.32","article-title":"Association of nitric oxide production and apoptosis in a model of experimental nephropathy","volume":"16","author":"Ozen","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2022.109583_b0265","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1681\/ASN.2007121336","article-title":"Mechanisms of Renal Apoptosis in Health and Disease","volume":"19","author":"Sanz","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0270","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/j.kint.2016.01.012","article-title":"Podocyte injury and its consequences","volume":"89","author":"Nagata","year":"2016","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2022.109583_b0275","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1152\/physrev.00020.2002","article-title":"Cell biology of the glomerular podocyte","volume":"83","author":"Pavenst\u00e4dt","year":"2003","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.intimp.2022.109583_b0280","doi-asserted-by":"crossref","first-page":"F1308","DOI":"10.1152\/ajprenal.00162.2016","article-title":"Podocyte injury: The role of proteinuria, urinary plasminogen, and oxidative stress","volume":"311","author":"Raij","year":"2016","journal-title":"Am. J. Physiol. Renal Physiol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109583_b0285","doi-asserted-by":"crossref","first-page":"e92003","DOI":"10.1371\/journal.pone.0092003","article-title":"cAMP Signaling Prevents Podocyte Apoptosis via Activation of Protein Kinase A and Mitochondrial Fusion","volume":"9","author":"Li","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2022.109583_b0290","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.jpedsurg.2018.04.013","article-title":"Beneficial effects of rolipram, a phosphodiesterase 4 specific inhibitor, on testicular torsion-detorsion injury in rats","volume":"53","author":"Abat","year":"2018","journal-title":"J. Pediatr. Surg."},{"key":"10.1016\/j.intimp.2022.109583_b0295","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3892\/etm.2015.2958","article-title":"Rolipram stimulates angiogenesis and attenuates neuronal apoptosis through the c_rfurl amp\/cAMP-responsive element binding protein pathway following ischemic stroke in rats","volume":"11","author":"Hu","year":"2016","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2022.109583_b0300","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1681\/ASN.2010030269","article-title":"Macrophages in renal disease","volume":"22","author":"Wang","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0305","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/ki.1991.229","article-title":"Initiation and evolution of interstitial leukocytic infiltration in experimental glomerulonephritis","volume":"40","author":"Lan","year":"1991","journal-title":"Kidney Int."},{"issue":"6","key":"10.1016\/j.intimp.2022.109583_b0310","first-page":"F779","article-title":"Sublethal X-irradiation during acute puromycin nephrosis prevents late renal injury: role of macrophages","volume":"260","author":"Diamond","year":"1991","journal-title":"Am. J. Phys. Anthropol."},{"key":"10.1016\/j.intimp.2022.109583_b0315","first-page":"168","article-title":"Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats: Terminal complement components are not the sole mediators of proteinuria","volume":"65","author":"Hara","year":"1991","journal-title":"Lab. Invest."},{"key":"10.1016\/j.intimp.2022.109583_b0320","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1172\/JCI110304","article-title":"Abrogation of macrophage-dependent injury in experimental glomerulonephritis in the rabbit Use of an antimacrophage serum","volume":"68","author":"Holdsworth","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2022.109583_b0325","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1681\/ASN.2010070693","article-title":"IL-25 induces M2 macrophages and reduces renal injury in proteinuric kidney disease","volume":"22","author":"Cao","year":"2011","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0330","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1111\/j.1523-1755.2005.00279.x","article-title":"Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis","volume":"67","author":"Khan","year":"2005","journal-title":"Kidney Int."},{"key":"10.1016\/j.intimp.2022.109583_b0335","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0952-7915(98)80163-5","article-title":"Regulation of interferon-gamma production by IL-12 and IL-18","volume":"10","author":"Okamura","year":"1998","journal-title":"Curr. Opin. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109583_b0340","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1172\/JCI1379","article-title":"Interleukin-18 (IFNgamma-inducing factor) induces IL-8 and IL-1beta via TNFalpha production from non-CD14+ human blood mononuclear cells","volume":"101","author":"Puren","year":"1998","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.intimp.2022.109583_b0345","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/MNH.0000000000000186","article-title":"Monocyte chemoattractant protein-1 and the kidney","volume":"25","author":"Haller","year":"2016","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.intimp.2022.109583_b0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/182958","article-title":"TNF superfamily: a growing saga of kidney injury modulators","volume":"2010","author":"Sanchez-Ni\u00f1o","year":"2010","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.intimp.2022.109583_b0355","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1681\/ASN.2017050523","article-title":"Exosomal CCL2 from Tubular Epithelial Cells Is Critical for Albumin-Induced Tubulointerstitial Inflammation","volume":"29","author":"Lv","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0360","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: A new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0365","unstructured":"A. Ortiz, C. Bustos, J. Alonso, R. Alc\u00e1zar, M.J. L\u00f3pez-Armada, J.J. Plaza, E. Gonz\u00e1lez, J. Egido, Involvement of tumor necrosis factor-alpha in the pathogenesis of experimental and human glomerulonephritis., Adv. Nephrol. Necker Hosp. 24 (1995) 53\u201377. https:\/\/europepmc.org\/article\/med\/7572422 (accessed March 29, 2022)."},{"key":"10.1016\/j.intimp.2022.109583_b0370","doi-asserted-by":"crossref","DOI":"10.1152\/ajpregu.1999.277.3.R922","article-title":"Early kidney TNF-\u03b1 expression mediates neutrophil infiltration and injury after renal ischemia-reperfusion","volume":"277","author":"Donnahoo","year":"1999","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0375","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1152\/ajprenal.00099.2004","article-title":"TNF-\u03b1 mediates obstruction-induced renal tubular cell apoptosis and proapoptotic signaling","volume":"288","author":"Misseri","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0380","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cytogfr.2006.09.011","article-title":"The role of TNF-\u03b1 in diabetic nephropathy: Pathogenic and therapeutic implications","volume":"17","author":"Navarro","year":"2006","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.intimp.2022.109583_b0385","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1053\/ajkd.2002.32769","article-title":"T-lymphocyte populations and cytokines in childhood nephrotic syndrome","volume":"39","author":"Lama","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2022.109583_b0390","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0272-6386(12)80742-6","article-title":"Elevated Levels of Tumor Necrosis Factor-\u03b1 in the Nephrotic Syndrome in Humans","volume":"21","author":"Suranyi","year":"1993","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.intimp.2022.109583_b0395","unstructured":"D. Youssef Mohammed, R. Mohammed Elbehidy, A. Saeed El-Shal, L. Metwaly Sherief, KIDNEY DISEASES T Helper 1 and T Helper 2 Cytokines in Atopic Children With Steroid-sensitive Nephrotic Syndrome, 2015. www.ijkd.org."},{"key":"10.1016\/j.intimp.2022.109583_b0400","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1152\/ajpcell.00153.2005","article-title":"TGF-\u03b21 stimulates monocyte chemoattractant protein-1 expression in mesangial cells through a phosphodiesterase isoenzyme 4-dependent process","volume":"289","author":"Cheng","year":"2005","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0405","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1172\/JCI118788","article-title":"Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV","volume":"98","author":"Tsuboi","year":"1996","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2022.109583_b0410","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1681\/ASN.2006070704","article-title":"Chronic kidney disease progression","volume":"17","author":"Eddy","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.intimp.2022.109583_b0415","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1093\/ndt\/14.9.2072","article-title":"Tubular epithelial cell activation and interstitial fibrosis. The role of glomerular ultrafiltration of growth factors in the nephrotic syndrome and diabetic nephropathy","volume":"14","author":"Wang","year":"1999","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.intimp.2022.109583_b0420","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.00215","article-title":"Long Non-coding RNAs Rian and Miat Mediate Myofibroblast Formation in Kidney Fibrosis","volume":"10","author":"Bijkerk","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.intimp.2022.109583_b0425","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1681\/ASN.2017050574","article-title":"Wnt9a Promotes Renal Fibrosis by Accelerating Cellular Senescence in Tubular Epithelial Cells","volume":"29","author":"Luo","year":"2018","journal-title":"J. Am. Soc. Nephrol."},{"issue":"3","key":"10.1016\/j.intimp.2022.109583_b0430","doi-asserted-by":"crossref","first-page":"e0191706","DOI":"10.1371\/journal.pone.0191706","article-title":"Fibroblast growth factor 23 is upregulated in the kidney in a chronic kidney disease rat model","volume":"13","author":"Sugiura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.intimp.2022.109583_b0435","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.lfs.2019.03.020","article-title":"Dihydroartemisinin attenuates renal fibrosis through regulation of fibroblast proliferation and differentiation","volume":"223","author":"Zhang","year":"2019","journal-title":"Life Sci."},{"key":"10.1016\/j.intimp.2022.109583_b0440","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/cells8020158","article-title":"Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling","volume":"8","author":"Berg","year":"2019","journal-title":"Cells."},{"key":"10.1016\/j.intimp.2022.109583_b0445","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.7150\/ijbs.25589","article-title":"Kupffer-derived matrix metalloproteinase-9 contributes to liver fibrosis resolution","volume":"14","author":"Feng","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.intimp.2022.109583_b0450","doi-asserted-by":"crossref","first-page":"L961","DOI":"10.1152\/ajplung.00455.2017","article-title":"Delayed resolution of bleomycin-induced pulmonary fibrosis in absence of MMP13 (collagenase 3)","volume":"316","author":"Cabrera","year":"2019","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"key":"10.1016\/j.intimp.2022.109583_b0455","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.2147\/DDDT.S165161","article-title":"Pharmacological mechanism of roflumilast in the treatment of asthma\u2013COPD overlap","volume":"12","author":"Zhang","year":"2018","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.intimp.2022.109583_b0460","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/PTT.S303634","article-title":"Phosphodiesterase-4 Inhibition in Psoriasis","volume":"11","author":"Milakovic","year":"2021","journal-title":"Psoriasis: Targets Therapy."},{"issue":"6","key":"10.1016\/j.intimp.2022.109583_b0465","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat. Rev. Nephrol."}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922010682?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576922010682?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T14:02:55Z","timestamp":1736431375000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576922010682"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":93,"alternative-id":["S1567576922010682"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109583","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Therapeutic treatment with phosphodiesterase-4 inhibitors alleviates kidney injury and renal fibrosis by increasing MMP-9 in a doxorubicin-induced nephrotoxicity mouse model","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2022.109583","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109583"}}